Document is current
Any future updates will be listed below
-
Authors
Heckmann, Neele
Plage, Henning
Simon, Ronald https://orcid.org/0000-0003-0158-4258
Lennartz, Maximilian https://orcid.org/0000-0002-1572-8200
Fraune, Christoph
Jacobsen, Frank
Krech, Till
Lebok, Patrick
Minner, Sarah
Burandt, Eike
Clauditz, Till S.
Wilczak, Waldemar
Sauter, Guido
Gorbokon, Natalia
Freytag, Morton https://orcid.org/0009-0001-3841-444X
Lutz, Florian
Reiswich, Viktor
Viehweger, Florian
Chirico, Viktoria
Heinzer, Hans
Haese, Alexander https://orcid.org/0000-0001-9339-9521
Schlomm, Thorsten
Marx, Andreas
Graefen, Markus
Steurer, Stefan
Bernreuther, Christian
Ralla, Bernhard
Dum, David https://orcid.org/0000-0002-7884-4313
Hinsch, Andrea
Kind, Simon
Luebke, Andreas M.
Menz, Anne
Möller, Katharina
Schlichter, Ria
Weidemann, Sören
Erber, Barbara
Biernath, Nadine
Weinberger, Sarah
- License Information
-
More Information
Article History
Received: 29 November 2024
Revised: 14 August 2025
Accepted: 16 October 2025
First Online: 5 November 2025
Competing interests
: The GR antibody, clone HMV304 was provided from ardoci GmbH, Hamburg, Germany (owned by a family member of GS).
: The use of archived remnants of diagnostic tissues for manufacturing of TMAs and their analysis for research purposes as well as patient data analysis has been approved by local laws (HmbKHG, §12) and by the local ethics committee (Ethics commission Hamburg, WF-049/09). All work has been carried out in compliance with the Helsinki Declaration. Patient consent was waived due to local laws (HmbKHG, §12,1) that permit research with anonymized diagnostic left-over tissue samples.
